Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Key genes linked to hair growth and cancer were identified in hairless mice.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Methamphetamine affects gene expression in rat whisker follicles, with key genes linked to addiction.

miRNAs could help diagnose and treat gouty arthritis.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Alopecia areata affects quality of life more in adolescents than adults.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.